نتائج البحث

Atezolizumab, Obinutuzumab, and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Relapsed or Refractory Richter Syndrome

• Authors : National Cancer Institute (NCI)

• Source: Atezolizumab (PD-L1 mAb) in Combination With Obinutuzumab and Venetoclax for Patients With Chronic Lymphocytic Leukemia and Richter Transformation

تفاصيل العنوان

Staging of cancer.

• Authors : Conboy, Pam, BS

Subjects: Tumor classification; Tumor grading; Cancer

• Source: Salem Press Encyclopedia of Health, 2024. 3p.

تفاصيل العنوان

A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL

• Authors : Eli Lilly and Company

• Source: A Phase 1/2 Study of Oral LOXO-305 in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) or Non-Hodgkin Lymphoma (NHL)

تفاصيل العنوان

Genetic Profiling in Chronic Lymphocytic Leukemia: The Role of TP53 Mutations and IGHV Status in Treatment Decision-Making – A Case Report

• Authors : Kateryna Khurdepa; Oksana Karnabeda

Subjects: chronic lymphocytic leukemia; chemoimmunotherapy; ighv mutation status

• Source: Galician Medical Journal (2024)

تفاصيل العنوان

Immunosuppression and COVID-19 Boosters

• Authors : Seqirus Pty Ltd, Australia; Medical Research Future Fund

• Source: Comparison of Immunity-boosting Regimens for COVID-19 Upon Initiation of Immunosuppressive Therapy

تفاصيل العنوان

Genetically Risk-Stratified Venetoclax, Ibrutinib, Rituximab (± Navitoclax) in Relapsed/Refractory Mantle Cell Lymphoma

• Source: A Phase II Study of Genetically Risk-Stratified Combination of Venetoclax, Ibrutinib and Rituximab (With and Without Navitoclax) in Patients With Relapsed and Refractory Mantle Cell Lymphoma (AIM2)

تفاصيل العنوان

A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy

• Authors : James Gulley, M.D., Principal Investigator

• Source: A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid

تفاصيل العنوان

LncRNA Nicotinamide Nucleotide Transhydrogenase-Antisense RNA1 NNT-AS1 in CRC

• Authors : Prof. Nadia M. Hamdy, Ph.D., professor of biochemistry and molecular biology

• Source: LncRNA NNT-AS1/Hsa-miR-485-5p/HSP90 Axis In-silico and Clinical Prospect correlated-to Histologic Grades-based CRC Stratification: A Step Toward ncRNA PrecisionEl-Sheikh NM, Abulsoud AI, Fawzy

تفاصيل العنوان

Blood cancers.

• Authors : Peterman, Susan H., MPH

Subjects: Bone marrow diseases; Hematologic malignancies

• Source: Salem Press Encyclopedia of Health, 2024. 3p.

تفاصيل العنوان

Phase I Study of CTL Anti-DP Infusion Post-hematopoietic Stem Cell Transplantation (CTL-DP 01)

• Authors : INSERM U01232 CRCINA

• Source: A Phase 1 Dose-escalation Study Testing the Feasibility and the Tolerance of Infusion of a Specific Third Party Suicide Gene-transduced Anti-HLA-DPB1*0401 CD4+ T Cell Clone in HLA-DPB1*04:01 Positive

تفاصيل العنوان